Skip to main content

By Market & Region

Filter fairsonline.org news by target market and region. Use the dropdown above to focus on the markets most relevant to your business.

Optimizely Launches Virtual Teammates, AI Coworkers for Marketers

Image
Optimizely Launches Virtual Teammates, AI Coworkers for Marketers

NEW YORK -- September 01, 2026 -- Optimizely unveiled Virtual Teammates on Aug. 31, 2026 at its Opticon conference, a new class of AI coworkers built to take on defined marketing roles instead of responding to individual prompts. The launch includes five role-specific digital coworkers: Chief of Staff, SEO & AI Search Analyst, Marketing Analyst, Personalization Strategist, and CRO Manager. Each retains organizational context over time and operates across marketing tools under its own identity and permissions.

81% of B2B Marketing Leaders Juggle Multiple Disconnected AI Tools Weekly

A global Optimizely study of more than 2,000 B2B marketing leaders found that 81% personally switch between two or more disconnected AI tools each week, including 19% who use four or more. Optimizely said Virtual Teammates are built to function as ongoing members of the marketing team rather than an additional standalone tool marketers have to operate.

Yorkville America Launches FRUT ETF Blending AI Platforms and Chip Suppliers

MOUNTAINSIDE, N.J. -- September 01, 2026 -- Yorkville America Equities, LLC launched the Yorkville America MANGOS Plus Index ETF, trading under ticker FRUT on NYSE Arca and NYSE Texas, the firm announced Aug. 31, 2026. The fund combines six AI platform companies with seven hardware and infrastructure suppliers inside a single rules-based index, charging a 0.50% expense ratio with quarterly distributions. Tidal Investments, LLC serves as sub-adviser, and PINE Distributors LLC acts as distributor.

FRUT commits 80% of assets to twelve named AI companies

At least 80% of the fund's net assets go toward what Yorkville America calls the MANGO Plus Group: Meta Platforms, NVIDIA, Alphabet, SpaceX, OpenAI and Anthropic, plus SanDisk, Marvell, Micron, Intel, Dell, AMD and Broadcom. Exposure comes through direct holdings, private securities or total return swaps, with direct private-security holdings capped at 5% of net assets.

Klinikum Frankfurt (Oder) Opens €6 Million Hybrid Operating Room

Image
Klinikum Frankfurt (Oder) Opens €6 Million Hybrid Operating Room

Frankfurt (Oder), Germany -- Klinikum Frankfurt (Oder) opened a new hybrid operating room on Aug. 31, 2026, backed by roughly 6 million euros in investment, RHÖN-KLINIKUM AG announced. The facility, one of five hospitals in the Rhön-Klinikum network, will serve as the primary site for vascular surgery and cardiology teams treating complex vascular and cardiac cases across eastern Brandenburg. Hospital managing director Christian Petersen and chief medical officer Prof. Richter-Ehrenstein presented the room as a step toward offering high-end interventional procedures rarely available outside specialized centers.

Corvex to Boost AI Data Center Capacity 5x on $33M Raise

Image
Corvex to Boost AI Data Center Capacity 5x on $33M Raise

ARLINGTON, VA. -- September 01, 2026 -- Corvex, Inc. (Nasdaq: MOVE) said it will lift critical IT power capacity fivefold, from roughly 1.5 megawatts to approximately 8 megawatts by year-end 2026, backed by a $33 million private placement led by Goldman Sachs & Co. LLC, Morgan Stanley and Oppenheimer & Co. The Arlington, Virginia-based AI infrastructure provider is doubling its existing Mid-Atlantic data center and standing up a second facility in the Midwest, with both sites expected ready for service in the fourth quarter of 2026. A right of first refusal on 12.5 additional megawatts at the Midwest site could push total capacity past 20 megawatts, a 13-fold jump from current levels.

CollPlant to Acquire LightSolver, Entering Photonic Computing Market

Image
CollPlant to Acquire LightSolver, Entering Photonic Computing Market

REHOVOT, Israel -- September 01, 2026 -- CollPlant Biotechnologies Ltd. (Nasdaq: CLGN) has signed a definitive agreement to acquire LightSolver Ltd., an Israeli developer of laser-based computing hardware, in a deal expected to close this week. The transaction moves CollPlant, a regenerative-medicine company known for recombinant collagen products, into supercomputing and photonic computing. LightSolver's technology has already been tested by Boeing, a top-tier global financial institution and unnamed defense, energy and engineering-software companies.

Veloxis Doses First Patient in Phase 2 Kidney Transplant Drug Trial

Image
Veloxis Doses First Patient in Phase 2 Kidney Transplant Drug Trial

CARY, N.C. -- September 01, 2026 -- Veloxis Pharmaceuticals dosed the first participant on Aug. 31, 2026, in its Phase 2 RENGEVITY-201 trial testing pegrizeprument, an investigational immunosuppressive drug, against tacrolimus in kidney transplant recipients. The Cary, North Carolina-based company, a unit of Asahi Kasei Corporation, will enroll up to 120 de novo kidney transplant patients across multiple sites in the randomized, partially blinded study registered as NCT07290777. Patients will receive one of two pegrizeprument doses or tacrolimus, each layered on top of rATG, corticosteroids and mycophenolate maintenance therapy.

Perpetua Advances Stibnite Gold Project as Court Upholds Permits

Image
Perpetua Advances Stibnite Gold Project as Court Upholds Permits

Boise, Idaho -- September 01, 2026 -- Perpetua Resources Corp. (Nasdaq: PPTA; TSX: PPTA) said dual autoclaves for its Stibnite Gold Project in central Idaho are now being fabricated at a custom facility in Europe, one of several construction milestones the company detailed on August 31, 2026. Four drill rigs have completed roughly 5,800 meters of a 10,000-meter 2026 exploration program that has returned high-grade gold, antimony and tungsten intercepts. The update follows an August 18, 2026 ruling by the U.S. District Court of Idaho upholding federal approvals for the project, and a July 29, 2026 ribbon-cutting for a military antimony processing plant at Idaho National Laboratory.

Transformer Monitoring Market to Hit $4.98B by 2031, MarketsandMarkets Says

Image
Transformer Monitoring Market to Hit $4.98B by 2031, MarketsandMarkets Says

Delray Beach, Fla. -- Aug. 31, 2026 -- The global transformer monitoring market will grow from $3.11 billion in 2026 to $4.98 billion by 2031, a 9.9% compound annual growth rate, according to MarketsandMarkets. The firm placed the 2025 market size at $2.84 billion. Utilities and industrial operators are driving the expansion by prioritizing transformer reliability and asset health as aging fleets and rising renewable integration strain existing grid infrastructure.

NameSilo Technologies Posts Record C$18.8M Q2 Revenue, Bookings Up 40.7%

Image
NameSilo Technologies Posts Record C$18.8M Q2 Revenue, Bookings Up 40.7%

VANCOUVER, BC -- September 01, 2026 -- NameSilo Technologies Corp. reported record second-quarter revenue of C$18.8 million for the period ended June 30, 2026, up 16.6% from C$16.1 million a year earlier, the domain registrar announced Aug. 31, 2026. Total bookings climbed 40.7% to a record C$22.6 million from C$16.1 million in Q2 2025. Net income rose to C$1.44 million from C$1.17 million, while gross margin expanded to 28.5% of revenue from 25.6% a year earlier.

Gross Profit Rises to $5.35 Million as Domain and Marketplace Revenue Grows

Gross profit reached C$5,350,193 in the quarter, up from C$4,122,496 in Q2 2025. NameSilo attributed the revenue increase to growth in domains under management, marketplace transactions, ancillary services, and contributions from its two operating subsidiaries, SewerVue Technologies and Reach Systems. NameSilo LLC now manages roughly 6.2 million active domains across approximately 160 countries.

Lilly to Pay Up to $2.875B for Merida Biosciences' Antibody Platform

Image
Lilly to Pay Up to $2.875B for Merida Biosciences' Antibody Platform

INDIANAPOLIS and CAMBRIDGE, Mass. -- Aug. 31, 2026 -- Eli Lilly and Company agreed to pay up to $2.875 billion in cash to acquire Merida Biosciences, a Cambridge, Massachusetts-based biotechnology company developing antibody-degrading therapies for autoimmune and allergic diseases. The figure includes an upfront payment plus contingent milestone payments under a definitive agreement announced by both companies. The transaction is subject to customary closing conditions, including regulatory approvals, and is expected to close in the fourth quarter of 2026.

TCL CSOT Debuts IJP OLED Lineup, Cites $156 Billion Display Market by 2030

Image
TCL CSOT Debuts IJP OLED Lineup, Cites $156 Billion Display Market by 2030

Shanghai -- September 01, 2026 -- TCL CSOT opened its exhibition at the Display Innovation China Expo 2026 in Shanghai on Aug. 31, presenting a lineup of OLED, Micro LED and automotive display technologies. The company said its inkjet-printed (IJP) OLED technology has already reached mass production in the professional display sector and is now being validated with device brands for consumer laptops and monitors. Executives cited industry data projecting the global display market to grow from $123 billion in 2022 to $156 billion by 2030.

Oppenheimer Adds Former UNC Star Joel Berry II to NC Advisory Team

NEW YORK -- September 01, 2026 -- Oppenheimer & Co. Inc. hired Joel Berry II as a Financial Advisor to its Robinson Private Client Group in Winston-Salem, North Carolina, the firm announced on Aug. 31, 2026. Berry arrives from Truist Financial to expand the team's advisory work with current and former athletes navigating Name, Image and Likeness deals and revenue-sharing arrangements. The Robinson Private Client Group, led by Managing Director Tanner G. Robinson, oversaw more than $6 billion in client assets as of June 30, 2026.

IDEAYA Sets Phase 3 Design for IDE849 After FDA Type C Meeting

Image
IDEAYA Sets Phase 3 Design for IDE849 After FDA Type C Meeting

SOUTH SAN FRANCISCO, Calif. -- September 01, 2026 -- IDEAYA Biosciences said its FDA Type C meeting on IDE849, a DLL3-targeting antibody drug conjugate, produced agreement on a Phase 3 registrational trial design for extensive stage small cell lung cancer (ES-SCLC). The Nasdaq-listed company (IDYA) plans to enroll roughly 400 patients who have already received tarlatamab, randomizing them 1:1 between IDE849 monotherapy and an investigator's choice control arm of topotecan and amrubicin. IDEAYA is targeting trial initiation by year-end 2026.

So-Young Revenue Hits RMB505.2M as Aesthetic Treatment Sales Jump 130%

BEIJING -- September 01, 2026 -- So-Young International Inc. (Nasdaq: SY) reported total revenue of RMB505.2 million ($74.5 million) for the second quarter ended June 30, 2026, up 33.4% from RMB378.7 million a year earlier. The Beijing-based aesthetic treatment platform said revenue from its branded aesthetic centers jumped 129.5% to RMB331.4 million, exceeding the high end of its own guidance. Net loss attributable to the company narrowed to RMB22.7 million from RMB36.0 million in the second quarter of 2025.

NOP Drill Hole MM26-10 Shows Heavy Metals Well Below Organic Limits

Image
NOP Drill Hole MM26-10 Shows Heavy Metals Well Below Organic Limits

Vancouver, BC -- September 01, 2026 -- Nevada Organic Phosphate Inc. (CSE: NOP, OTCQB: NOPFF) reported that drill hole MM26-10 at its Murdock Mountain project in northeast Nevada returned 10.89% P2O5 over 3.60 metres, with heavy metal contaminant levels far below the thresholds required for organic fertilizer certification. The hole marked a 1.5-kilometre step-out along strike from intercepts the company disclosed Aug. 26, 2026. Nevada Organic Phosphate also disclosed a US$25,000 paid research agreement with Emerging Growth Research LLC to produce an investor report within four to six weeks.

Data Dynamics Debuts Enterprise 2.0.5 at LEAP 2026 for AI Data Governance

Image
Data Dynamics Debuts Enterprise 2.0.5 at LEAP 2026 for AI Data Governance

RIYADH, Saudi Arabia -- August 31, 2026 -- Data Dynamics announced general availability of Enterprise 2.0.5 at LEAP 2026 in Riyadh. The company said 60% of AI projects stall due to data curation and AI-readiness gaps, prompting the release of a platform that enforces governance directly at the data layer. Enterprise 2.0.5 targets models pointed at unmapped data, agents with standing access to content, and compliance teams left proving control after incidents occur. The software is available now across cloud, on-premises, sovereign and air-gapped deployments.

Consumer365 Review Names CorelDRAW Top Print-Shop Design Tool for 2026

NEW YORK -- Aug. 31, 2026 -- Consumer365.org published a review of CorelDRAW Graphics Suite 2026 on Aug. 31, 2026, evaluating the software against the operational needs of print shops, sign shops, apparel and screen-printing businesses, in-house marketing teams, and professional designers. The review examined the full production path from client-supplied artwork to finished output, covering color separations, soft proofing, 1:1 scale work, prepress controls, file compatibility, and purchasing structure. Consumer365 concluded that production readiness, not creative features alone, should drive small-business software decisions.

YFORE Unveils UWB Radar Portfolio With 99% In-Cabin Detection Rate

Image
YFORE Unveils UWB Radar Portfolio With 99% In-Cabin Detection Rate

SUWANEE, Ga. -- September 01, 2026 -- YFORE Technology unveiled an expanded ultra-wideband (UWB) radar sensor portfolio at its Suwanee, Georgia facility on August 31, 2026. The automotive Tier 1 supplier said the system achieves a life-detection rate above 99% for in-cabin monitoring, with signal leakage through windows kept below 20 cm. YFORE positioned the technology across four vehicle functions: cabin safety, vehicle access, perimeter security and automated parking, built on proprietary high-precision algorithms rather than optical line-of-sight sensors.

YFORE Opens Georgia Plant, Launches Anti-Pinch Sensors for US OEMs

SUWANEE, Georgia -- September 01, 2026 -- Tier-1 automotive supplier YFORE Technology has officially opened its manufacturing plant in Suwanee, Georgia, to produce anti-pinch sensor systems for North American automakers. The facility allows YFORE to supply automotive-grade closing sensor systems directly to regional OEMs under nearshore manufacturing, meeting local safety standards. The company said the sensors are already market-proven and now enter serial production at the new site.

Qinghai-Xizang Railway Marks 20 Years, 104 Million Passenger Trips

Image
Qinghai-Xizang Railway Marks 20 Years, 104 Million Passenger Trips

XINING, China -- September 01, 2026 -- The Qinghai-Xizang Railway, a 1,956-kilometer line linking Xining in Qinghai province to Lhasa in the Xizang autonomous region, has carried 104 million passenger trips and moved more than 824 million tonnes of cargo since opening. The Golmud-Lhasa section, which opened on July 1, 2006 at an average elevation of 4,440 meters, has now completed two decades of continuous operation. Science and Technology Daily detailed the engineering systems, developed with support from China State Railway Group Co., Ltd. and China Railway Group's Northwest Research Institute Co., Ltd., that keep trains running through permafrost and low-oxygen terrain.